Sonoma Pharmaceuticals Inc (SNOA)

$3.86 +0.18 (4.89%)
Market Cap 6.34M
Revenue (ttm) 14.29M
Net Income (ttm) -3.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.21%
Debt to Equity Ratio 0.00
Volume 14,000
Avg Vol 108,120
Day's Range N/A - N/A
Shares Out 1.64M
Stochastic %K 43%
Beta 1.46
Analysts Sell
Price Target $14.80

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 800 759 9305
Address:
5445 Conestoga Court, Suite 150, Boulder, United States
Don_Frye
Don_Frye Oct. 24 at 5:57 PM
$SNOA hahaha somebody wants in
0 · Reply
Bigdubs
Bigdubs Oct. 23 at 10:02 PM
$SNOA WTF mate... What did Bruce do to you Amy!?
0 · Reply
Benderama8
Benderama8 Oct. 23 at 9:50 PM
$SNOA Amy Trombly fired Bruce Thornton FOR CAUSE without pay, LOL. Put a fork in this company, they are done.
1 · Reply
SimpleLogic85
SimpleLogic85 Oct. 22 at 1:07 PM
$SNOA this stupid shit not doi g nothing
0 · Reply
bobby1618
bobby1618 Oct. 18 at 2:01 AM
$SNOA looks like a really good investment I'm buying on Monday
0 · Reply
BenGang
BenGang Oct. 16 at 10:32 PM
$SNOA
0 · Reply
Dickman777
Dickman777 Oct. 15 at 1:13 PM
$INV added here $SNOA gather what you can and thank yourself!!
0 · Reply
Jimmystocks6967
Jimmystocks6967 Oct. 14 at 6:22 PM
$SNOA how is this red on that news? Weird not even a few cents up looks like good news could be millions of $
1 · Reply
Bigdubs
Bigdubs Oct. 14 at 3:45 PM
$SNOA Amy still can’t get the volume to fund her ATM on two PRs.
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 14 at 12:32 PM
$SNOA Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
0 · Reply
Latest News on SNOA
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

Oct 14, 2025, 8:30 AM EDT - 11 days ago

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Oct 7, 2025, 8:30 AM EDT - 18 days ago

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Sep 25, 2025, 4:01 PM EDT - 4 weeks ago

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 26, 2025, 8:30 AM EDT - 2 months ago

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Aug 13, 2025, 4:01 PM EDT - 2 months ago

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Aug 7, 2025, 4:15 PM EDT - 2 months ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Jun 17, 2025, 4:10 PM EDT - 4 months ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Apr 22, 2025, 4:01 PM EDT - 6 months ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Mar 10, 2025, 4:01 PM EDT - 8 months ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 25, 2025, 4:01 PM EST - 8 months ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Feb 5, 2025, 4:05 PM EST - 9 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Dec 5, 2024, 8:30 AM EST - 11 months ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 21, 2024, 4:06 PM EST - 1 year ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 11, 2024, 4:20 PM EST - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Nov 7, 2024, 8:45 AM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 31, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 22, 2024, 8:35 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Oct 21, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 28, 2024, 6:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 26, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 21, 2024, 8:45 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Jun 17, 2024, 5:00 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

May 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 28, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Mar 27, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Feb 8, 2024, 4:10 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 23, 2024, 7:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

NBY

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 13, 2023, 4:10 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Nov 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Oct 26, 2023, 9:10 AM EDT - 2 years ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 15, 2023, 7:30 AM EDT - 2 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Jun 22, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Jun 9, 2023, 5:05 PM EDT - 2 years ago

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

Jun 8, 2023, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

Apr 11, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

Mar 28, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Mar 2, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Feb 14, 2023, 4:30 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Jan 31, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Jan 25, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Don_Frye
Don_Frye Oct. 24 at 5:57 PM
$SNOA hahaha somebody wants in
0 · Reply
Bigdubs
Bigdubs Oct. 23 at 10:02 PM
$SNOA WTF mate... What did Bruce do to you Amy!?
0 · Reply
Benderama8
Benderama8 Oct. 23 at 9:50 PM
$SNOA Amy Trombly fired Bruce Thornton FOR CAUSE without pay, LOL. Put a fork in this company, they are done.
1 · Reply
SimpleLogic85
SimpleLogic85 Oct. 22 at 1:07 PM
$SNOA this stupid shit not doi g nothing
0 · Reply
bobby1618
bobby1618 Oct. 18 at 2:01 AM
$SNOA looks like a really good investment I'm buying on Monday
0 · Reply
BenGang
BenGang Oct. 16 at 10:32 PM
$SNOA
0 · Reply
Dickman777
Dickman777 Oct. 15 at 1:13 PM
$INV added here $SNOA gather what you can and thank yourself!!
0 · Reply
Jimmystocks6967
Jimmystocks6967 Oct. 14 at 6:22 PM
$SNOA how is this red on that news? Weird not even a few cents up looks like good news could be millions of $
1 · Reply
Bigdubs
Bigdubs Oct. 14 at 3:45 PM
$SNOA Amy still can’t get the volume to fund her ATM on two PRs.
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 14 at 12:32 PM
$SNOA Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
0 · Reply
SPACEDAD
SPACEDAD Oct. 8 at 8:58 AM
$SNOA starting a small position here, popped up 2 days in a row on my scanner.
1 · Reply
Jitbag22
Jitbag22 Oct. 7 at 3:35 PM
$SNOA 0 short shares G
1 · Reply
Ididize
Ididize Oct. 7 at 1:30 PM
$SNOA Float ≈ 1.6 million shares — that’s tiny
0 · Reply
Ididize
Ididize Oct. 7 at 1:28 PM
$SNOA According to industry reports, the U.S. skin care market is projected to reach nearly $40 billion by 2030 https://finance.yahoo.com/news/sonoma-pharmaceuticals-expands-market-reach-123000924.html
0 · Reply
DARKP00L
DARKP00L Oct. 7 at 1:02 PM
$SNOA 08:48 on Oct. 07 2025 Sonoma Pharmaceuticals Highlights FDA Cosmetic Product Facility Registration, Microcyn-Based Cosmetic Product Listing Under MoCRA #tradeideas
0 · Reply
DARKP00L
DARKP00L Oct. 7 at 12:53 PM
$SNOA 08:48 on Oct. 07 2025 Sonoma Pharmaceuticals Highlights FDA Cosmetic Product Facility Registration, Microcyn-Based Cosmetic Product Listing Under MoCRA #tradeideas
0 · Reply
Omaroio
Omaroio Oct. 7 at 11:03 AM
$SNOA
0 · Reply
LukasPodolski
LukasPodolski Oct. 7 at 10:27 AM
$SNOA low floater on the run !! yesterday $SPRB today $GLTO maybe $SNOA is next - strong watch
0 · Reply
Omaroio
Omaroio Oct. 6 at 5:35 PM
$SNOA
0 · Reply
Omaroio
Omaroio Oct. 6 at 3:31 PM
$SNOA
0 · Reply
Invest863
Invest863 Oct. 6 at 3:23 PM
$SNOA LOW FLOAT, STRENGTH STRONG
0 · Reply
noname10000
noname10000 Oct. 6 at 2:41 PM
$SNOA what's going on here?
1 · Reply